IBDEI2TU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45092,1,3,0)
 ;;=3^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,45092,1,4,0)
 ;;=4^L51.2
 ;;^UTILITY(U,$J,358.3,45092,2)
 ;;=^5009206
 ;;^UTILITY(U,$J,358.3,45093,0)
 ;;=B35.0^^170^2246^2
 ;;^UTILITY(U,$J,358.3,45093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45093,1,3,0)
 ;;=3^Tinea Barae/Capitis
 ;;^UTILITY(U,$J,358.3,45093,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,45093,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,45094,0)
 ;;=B36.3^^170^2246^3
 ;;^UTILITY(U,$J,358.3,45094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45094,1,3,0)
 ;;=3^Tinea Blanca
 ;;^UTILITY(U,$J,358.3,45094,1,4,0)
 ;;=4^B36.3
 ;;^UTILITY(U,$J,358.3,45094,2)
 ;;=^266864
 ;;^UTILITY(U,$J,358.3,45095,0)
 ;;=B36.1^^170^2246^7
 ;;^UTILITY(U,$J,358.3,45095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45095,1,3,0)
 ;;=3^Tinea Nigra
 ;;^UTILITY(U,$J,358.3,45095,1,4,0)
 ;;=4^B36.1
 ;;^UTILITY(U,$J,358.3,45095,2)
 ;;=^264999
 ;;^UTILITY(U,$J,358.3,45096,0)
 ;;=B36.0^^170^2246^10
 ;;^UTILITY(U,$J,358.3,45096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45096,1,3,0)
 ;;=3^Tinea Veriscolor
 ;;^UTILITY(U,$J,358.3,45096,1,4,0)
 ;;=4^B36.0
 ;;^UTILITY(U,$J,358.3,45096,2)
 ;;=^5000608
 ;;^UTILITY(U,$J,358.3,45097,0)
 ;;=L81.8^^170^2246^1
 ;;^UTILITY(U,$J,358.3,45097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45097,1,3,0)
 ;;=3^Tattoo Pigmentation
 ;;^UTILITY(U,$J,358.3,45097,1,4,0)
 ;;=4^L81.8
 ;;^UTILITY(U,$J,358.3,45097,2)
 ;;=^5009318
 ;;^UTILITY(U,$J,358.3,45098,0)
 ;;=L80.^^170^2247^12
 ;;^UTILITY(U,$J,358.3,45098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45098,1,3,0)
 ;;=3^Vitiligo
 ;;^UTILITY(U,$J,358.3,45098,1,4,0)
 ;;=4^L80.
 ;;^UTILITY(U,$J,358.3,45098,2)
 ;;=^127071
 ;;^UTILITY(U,$J,358.3,45099,0)
 ;;=I83.019^^170^2247^7
 ;;^UTILITY(U,$J,358.3,45099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45099,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Site Unspec
 ;;^UTILITY(U,$J,358.3,45099,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,45099,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,45100,0)
 ;;=I83.029^^170^2247^2
 ;;^UTILITY(U,$J,358.3,45100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45100,1,3,0)
 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Site Unspec
 ;;^UTILITY(U,$J,358.3,45100,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,45100,2)
 ;;=^5007986
 ;;^UTILITY(U,$J,358.3,45101,0)
 ;;=I83.012^^170^2247^8
 ;;^UTILITY(U,$J,358.3,45101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45101,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer of Calf
 ;;^UTILITY(U,$J,358.3,45101,1,4,0)
 ;;=4^I83.012
 ;;^UTILITY(U,$J,358.3,45101,2)
 ;;=^5007974
 ;;^UTILITY(U,$J,358.3,45102,0)
 ;;=I83.013^^170^2247^9
 ;;^UTILITY(U,$J,358.3,45102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45102,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer of Ankle
 ;;^UTILITY(U,$J,358.3,45102,1,4,0)
 ;;=4^I83.013
 ;;^UTILITY(U,$J,358.3,45102,2)
 ;;=^5007975
 ;;^UTILITY(U,$J,358.3,45103,0)
 ;;=I83.014^^170^2247^10
 ;;^UTILITY(U,$J,358.3,45103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45103,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer of Heel/Midfoot
 ;;^UTILITY(U,$J,358.3,45103,1,4,0)
 ;;=4^I83.014
 ;;^UTILITY(U,$J,358.3,45103,2)
 ;;=^5007976
 ;;^UTILITY(U,$J,358.3,45104,0)
 ;;=I83.11^^170^2247^6
 ;;^UTILITY(U,$J,358.3,45104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45104,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Inflammation
